Alex D'SouzaManaging Editoreditor@healthcaretechoutlook.comThe graph of oncology treatments was never linear but characterized by ups and downs. It was during the 1930s when German scientist Paul Ehrlich first coined the term "chemotherapy" to describe the chemical treatment procedure of cancer. However, the search for a perfect treatment procedure that helps in complete remission of the disease is still on. Besides chemotherapy, therapeutic arsenal, alongside surgery in the case of solid tumors, antitumor drugs, and radiation processes has been the treatment of choice for many years now. But owing to the advancements in medicine and research processes, scientists and doctors firmly believe that we're heading towards a brighter era in cancer care and treatment. As precision medicine is becoming the ultimate oncology solution, investigators are developing new research approaches and perfecting basket trials to help doctors deliver precision-medicine options to more patients quickly. Besides, attempts are made to make checkpoint inhibitors that trigger immune defense mechanisms as the standard oncology care. In fact, researchers are leaving no stone unturned in formulating drugs that boost the cancer-fighting powers of the immune system's T cells. Standing at the cusp of cancer treatment solutions, there are a wide range of solution providers which offer the latest methods best suited for the next generation of oncology management needs. To help leaders navigate through the list of oncology solution providers, our panel comprising of CEOs, CIOs, VCs, industry analysts, and the editorial board of Healthcare Tech Outlook has narrowed down the top solution providers in this landscape that exhibit competence in delivering robust cancer treatment solutions and innovations. Equipped with innovative technological capabilities, these enlisted solution providers are transforming the oncology care paradigm at the cloverleaf of various disruptive technologies. We hope this issue of Healthcare Tech Outlook helps you build the partnership you and your organization need to foster an environment driven by robust and efficient technology. Let us know your thoughts!Checkpoint Inhibitors to Open New Doors in Oncology CareEditorialManaging EditorAlex D'SouzaEditorial StaffAaron PaulJoe PhillipJames SmithMark RobertVisualizerUTLOOKHealthcare Tech Copyright © 2021 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.UTLOOKHealthcare Tech *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEmail:sales@healthcaretechoutlook.comeditor@healthcaretechoutlook.commarketing@healthcaretechoutlook.comImmanuelJaxon JaseSalesRich Gonsalves rich@healthcaretechoutlook.comAPRIL - 26 - 2021, volume 07 - Issue 08 (ISSN 2691-3933) Published by ValleyMedia, Inc. To subscribe to HealthcareTech OutlookVisit www.healthcaretechoutlook.com
< Page 5 | Page 7 >